Streetbeat News

Stock Prices

SPY

A market on close imbalance of $6.4 billion to the sell-side has been reported, indicating a potential short-term downward pressure on stock prices.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 7:51 pm

ANNX

Annexon's stock is trading higher after BCIP Life Sciences Associates purchased 300,000 shares at an average price of $2.13, according to a Form4 filing.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 7:49 pm

TRKA

Troika Media Group announced a 1-for-25 reverse stock split, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 7:46 pm

GXC

KWEB

MCHI

China's manufacturing activity contracted for the second consecutive month in May, with the manufacturing PMI dropping to its lowest point since January. This has led to a decline in China ETFs, including iShares MSCI China ETF (MCHI), KraneShares CSI China Internet ETF (KWEB), and SPDR S&P China ETF (GXC). Analysts at Nomura expect the manufacturing PMI to remain in contraction during June.

Portfolio Pulse from Natan Ponieman

May 31, 2023 | 7:39 pm

PHIO

Phio Pharmaceuticals announced a $4 million concurrent registered direct offering and private placement priced at-the-market under Nasdaq rules, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 7:37 pm

AKBA

Akebia Therapeutics' stock has been upgraded from Neutral to Overweight by Piper Sandler, with the price target raised from $2 to $4.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 7:36 pm

SPY

A market on close imbalance of $2.3 billion to the sell-side has been reported, indicating a potential short-term downward pressure on stock prices.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 7:31 pm

EL

A large bearish position on Estee Lauder Cos (NYSE:EL) has been observed, with 65% of big-money traders showing bearish sentiment. Whales have been targeting a price range of $155 to $260 for Estee Lauder over the last 3 months.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 7:31 pm

AMBA

Ambarella (AMBA) reported better-than-expected Q1 earnings with an adjusted loss of 15 cents per share and revenue of $62.14 million. However, the company projected lower Q2 revenue of $60-64 million compared to estimates of $67.17 million. Several analysts lowered price targets, ranging from $70 to $100.

Portfolio Pulse from Ryan Gustafson

May 31, 2023 | 7:23 pm

AQST

Aquestive Therapeutics shares are trading higher after the company released positive topline clinical data from recent pilot studies following the End-of-Phase 2 meeting with the FDA.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 7:21 pm